Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Ködmön C[au]:

The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004-2014. Whittaker R et al. Vaccine. (2017)

Multidrug-resistant tuberculosis and migration to Europe. van der Werf MJ et al. Clin Microbiol Infect. (2017)

Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union. van der Werf MJ et al. Eur Respir J. (2017)

Search results

Items: 39

1.

Whole-Genome Sequencing as Tool for Investigating International Tuberculosis Outbreaks: A Systematic Review.

van der Werf MJ, Ködmön C.

Front Public Health. 2019 Apr 17;7:87. doi: 10.3389/fpubh.2019.00087. eCollection 2019.

2.

Improvement in serological diagnosis of pertussis by external quality assessment.

Markey K, Douglas-Bardsley A, Asokanathan C, Fry NK, Barkoff AM, Bacci S, Ködmön C, He Q.

J Med Microbiol. 2019 May;68(5):741-747. doi: 10.1099/jmm.0.000926. Epub 2019 Apr 16.

PMID:
30990403
3.

Role and value of whole genome sequencing in studying tuberculosis transmission.

Nikolayevskyy V, Niemann S, Anthony R, van Soolingen D, Tagliani E, Ködmön C, van der Werf MJ, Cirillo DM.

Clin Microbiol Infect. 2019 Apr 11. pii: S1198-743X(19)30124-7. doi: 10.1016/j.cmi.2019.03.022. [Epub ahead of print] Review.

PMID:
30980928
4.

Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014.

Karo B, Kohlenberg A, Hollo V, Duarte R, Fiebig L, Jackson S, Kearns C, Ködmön C, Korzeniewska-Kosela M, Papaventsis D, Solovic I, van Soolingen D, van der Werf MJ.

Euro Surveill. 2019 Mar;24(12). doi: 10.2807/1560-7917.ES.2019.24.12.1800392.

5.

Will we reach the Sustainable Development Goals target for tuberculosis in the European Union/European Economic Area by 2030?

Merk H, Ködmön C, van der Werf MJ.

Euro Surveill. 2019 Mar;24(12). doi: 10.2807/1560-7917.ES.2019.24.12.1900153.

6.

Molecular and genomic typing for tuberculosis surveillance: A survey study in 26 European countries.

Andrés M, van der Werf MJ, Ködmön C, Albrecht S, Haas W, Fiebig L; Survey study group.

PLoS One. 2019 Mar 13;14(3):e0210080. doi: 10.1371/journal.pone.0210080. eCollection 2019.

7.

EUSeqMyTB to set standards and build capacity for whole genome sequencing for tuberculosis in the EU.

Tagliani E, Cirillo DM, Ködmön C, van der Werf MJ; EUSeqMyTB Consortium.

Lancet Infect Dis. 2018 Apr;18(4):377. doi: 10.1016/S1473-3099(18)30132-4. Epub 2018 Mar 21. No abstract available.

PMID:
29582760
8.

Time-and-motion tool for the assessment of working time in tuberculosis laboratories: a multicentre study.

Mathys V, Roycroft E, Raftery P, Groenheit R, Folkvardsen DB, Homorodean D, Vasiliauskiene E, Vasiliauskaite L, Kodmon C, van der Werf MJ, Drobniewski F, Nikolayevskyy V.

Int J Tuberc Lung Dis. 2018 Apr 1;22(4):444-451. doi: 10.5588/ijtld.17.0564.

9.

Childhood multidrug-resistant tuberculosis in the European Union and European Economic Area: an analysis of tuberculosis surveillance data from 2007 to 2015.

Ködmön C, van den Boom M, Zucs P, van der Werf MJ.

Euro Surveill. 2017 Nov;22(47). doi: 10.2807/1560-7917.ES.2017.22.47.17-00103.

10.

Determinants of site of tuberculosis disease: An analysis of European surveillance data from 2003 to 2014.

Sotgiu G, Falzon D, Hollo V, Ködmön C, Lefebvre N, Dadu A, van der Werf M.

PLoS One. 2017 Nov 20;12(11):e0186499. doi: 10.1371/journal.pone.0186499. eCollection 2017.

11.

Shorter regimens for multidrug-resistant tuberculosis should also be applicable in Europe.

van der Werf MJ, Ködmön C, Catchpole M.

Eur Respir J. 2017 Jun 1;49(6). pii: 1700463. doi: 10.1183/13993003.00463-2017. Print 2017 Jun. No abstract available.

12.

Tuberculosis notification rate decreases faster in residents of native origin than in residents of foreign origin in the EU/EEA, 2010 to 2015.

Hollo V, Beauté J, Ködmön C, van der Werf MJ.

Euro Surveill. 2017 Mar 23;22(12). pii: 30486. doi: 10.2807/1560-7917.ES.2017.22.12.30486.

13.

Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union.

van der Werf MJ, Hollo V, Ködmön C, Dara M, Catchpole M.

Eur Respir J. 2017 Mar 22;49(3). pii: 1601992. doi: 10.1183/13993003.01992-2016. Print 2017 Mar. No abstract available.

14.

The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004-2014.

Whittaker R, Dias JG, Ramliden M, Ködmön C, Economopoulou A, Beer N, Pastore Celentano L; ECDC network members for invasive meningococcal disease.

Vaccine. 2017 Apr 11;35(16):2034-2041. doi: 10.1016/j.vaccine.2017.03.007. Epub 2017 Mar 14.

15.

Multidrug-resistant tuberculosis and migration to Europe.

van der Werf MJ, Hollo V, Ködmön C.

Clin Microbiol Infect. 2017 Aug;23(8):578-579. doi: 10.1016/j.cmi.2017.02.017. Epub 2017 Feb 20. No abstract available.

16.

Tuberculosis and HIV coinfection in Europe: looking at one reality from two angles.

van der Werf MJ, Ködmön C, Zucs P, Hollo V, Amato-Gauci AJ, Pharris A.

AIDS. 2016 Nov 28;30(18):2845-2853.

17.

External Quality Assessment for Tuberculosis Diagnosis and Drug Resistance in the European Union: A Five Year Multicentre Implementation Study.

Nikolayevskyy V, Hillemann D, Richter E, Ahmed N, van der Werf MJ, Kodmon C, Drobniewski F, Ruesch-Gerdes S; ERLTB-Net Network.

PLoS One. 2016 Apr 7;11(4):e0152926. doi: 10.1371/journal.pone.0152926. eCollection 2016.

18.
19.

The effect of migration within the European Union/European Economic Area on the distribution of tuberculosis, 2007 to 2013.

Hollo V, Kotila SM, Ködmön C, Zucs P, van der Werf MJ.

Euro Surveill. 2016;21(12). doi: 10.2807/1560-7917.ES.2016.21.12.30171.

20.

Second worldwide proficiency study on variable number of tandem repeats typing of Mycobacterium tuberculosis complex.

de Beer JL, Ködmön C, van Ingen J, Supply P, van Soolingen D; Global Network for Molecular Surveillance of Tuberculosis 2010.

Int J Tuberc Lung Dis. 2014 May;18(5):594-600. doi: 10.5588/ijtld.13.0531.

PMID:
24903798
21.

Molecular surveillance of multi- and extensively drug-resistant tuberculosis transmission in the European Union from 2003 to 2011.

De Beer JL, Kodmon C, van der Werf MJ, van Ingen J, van Soolingen D; ECDC MDR-TB Molecular Surveillance Project Participants.

Euro Surveill. 2014 Mar 20;19(11). pii: 20742.

22.

Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012.

van der Werf MJ, Ködmön C, Hollo V, Sandgren A, Zucs P.

Euro Surveill. 2014 Mar 13;19(10). pii: 20733.

23.

Inventory study of non-tuberculous mycobacteria in the European Union.

van der Werf MJ, Ködmön C, Katalinić-Janković V, Kummik T, Soini H, Richter E, Papaventsis D, Tortoli E, Perrin M, van Soolingen D, Zolnir-Dovč M, Ostergaard Thomsen V.

BMC Infect Dis. 2014 Feb 6;14:62. doi: 10.1186/1471-2334-14-62.

24.

Complete republication: Epidemiology of tuberculosis in the EU/EEA in 2010 - Monitoring the progress towards tuberculosis elimination.

Sandgren A, Hollo V, Huitric E, Ködmön C.

Eur J Microbiol Immunol (Bp). 2012 Dec;2(4):292-6. doi: 10.1556/EuJMI.2.2012.4.8. Epub 2012 Dec 11.

25.

Tuberculosis treatment outcome monitoring in European Union countries: systematic review.

van Hest R, Ködmön C, Verver S, Erkens CG, Straetemans M, Manissero D, de Vries G.

Eur Respir J. 2013 Mar;41(3):635-43. doi: 10.1183/09031936.00030612. Epub 2012 Jul 12. Review.

26.

Epidemiology of tuberculosis in the EU/EEA in 2010: monitoring the progress towards tuberculosis elimination.

Sandgren A, Hollo V, Huitric E, Kodmon C.

Euro Surveill. 2012 Mar 22;17(12). pii: 20124.

27.

First worldwide proficiency study on variable-number tandem-repeat typing of Mycobacterium tuberculosis complex strains.

de Beer JL, Kremer K, Ködmön C, Supply P, van Soolingen D; Global Network for the Molecular Surveillance of Tuberculosis 2009.

J Clin Microbiol. 2012 Mar;50(3):662-9. doi: 10.1128/JCM.00607-11. Epub 2011 Dec 14.

28.

Tuberculosis and HIV co-infection in European Union and European Economic Area countries.

Pimpin L, Drumright LN, Kruijshaar ME, Abubakar I, Rice B, Delpech V, Hollo V, Amato-Gauci A, Manissero D, Ködmön C.

Eur Respir J. 2011 Dec;38(6):1382-92. doi: 10.1183/09031936.00198410. Epub 2011 Jul 7. Review.

29.

The burden of TB-HIV in the EU: how much do we know? A survey of surveillance practices and results.

Kruijshaar ME, Pimpin L, Abubakar I, Rice B, Delpech V, Drumright LN, Hollo V, Huitric E, van de Laar M, Amato-Gauci A, Manissero D, Ködmön C.

Eur Respir J. 2011 Dec;38(6):1374-81. doi: 10.1183/09031936.00198310. Epub 2011 Jun 30.

30.

Marking 15 years of efforts towards a comprehensive European TB surveillance system: the epidemiological situation of TB in the EU/EEA in 2009.

Hollo V, Zucs P, Ködmön C, Sandgren A, Manissero D.

Euro Surveill. 2011 Mar 24;16(12). pii: 19822. No abstract available.

31.

Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area.

Ködmön C, Hollo V, Huitric E, Amato-Gauci A, Manissero D.

Euro Surveill. 2010 Mar 18;15(11). pii: 19519.

32.
33.

Tuberculosis in the EU and EEA/EFTA countries: what is the latest data telling us?

Hollo V, Amato-Gauci A, Kodmon C, Manissero D.

Euro Surveill. 2009 Mar 19;14(11). pii: 19151. Erratum in: Euro Surveill. 2009;14(13). pii: 19164.

34.

Molecular clues of a microepidemy among homeless tuberculosis patients in Budapest due to a new and local Mycobacterium tuberculosis clade.

Ködmön C, Niemann S, Gutierrez MC, Sola C, Rastogi N, Lukács J, Somoskövi A.

Infect Genet Evol. 2007 Sep;7(5):632-5. Epub 2007 Jun 22.

PMID:
17646135
35.

[Micro-epidemic due to a new Mycobacterium tuberculosis strain among the homeless in Budapest, Hungary].

Ködmön C, Lukács J, Stefan N, Dávid S, Vadász I, Somoskövy A.

Orv Hetil. 2007 Feb 25;148(8):339-42. Hungarian.

PMID:
17344156
36.

Molecular epidemiology of drug-resistant tuberculosis in Hungary.

Ködmön C, Niemann S, Lukács J, Sör E, Dávid S, Somoskövi A.

J Clin Microbiol. 2006 Nov;44(11):4258-61. Epub 2006 Sep 13.

37.

[Routine direct detection of Mycobacterium tuberculosis with a rapid test of polymerase chain reaction applied to a Hungarian patient population].

Somoskövi A, Bártfai Z, Ködmön C, Hutás I.

Orv Hetil. 2001 Sep 23;142(38):2085-90. Hungarian.

PMID:
11697065
38.

Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay.

Bártfai Z, Somoskövi A, Ködmön C, Szabó N, Puskás E, Kosztolányi L, Faragó E, Mester J, Parsons LM, Salfinger M.

J Clin Microbiol. 2001 Oct;39(10):3736-9.

39.

Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Löwenstein-Jensen medium.

Somoskövi A, Ködmön C, Lantos A, Bártfai Z, Tamási L, Füzy J, Magyar P.

J Clin Microbiol. 2000 Jun;38(6):2395-7.

Supplemental Content

Loading ...
Support Center